The Trump administration is considering a five-year pilot program to cover weight-loss drugs under Medicare and Medicaid, the ...

The Trump administration is planning an experiment to cover weight-loss drugs under Medicare and Medicaid, the Washington ...

The Washington Post editorial board argued a federal judge's ruling against congressional Medicaid restrictions on abortion ...

A five-year experiment aims to open access to blockbuster GLP‑1 drugs for obesity, something advocates have pushed for years.

The vice president is pitching the Trump administration’s signature policy achievement to a skeptical American public.

Republican National Committee Chairman Michael Whatley has launched his campaign for North Carolina’s open U.S. Senate seat ...

The federal government is expected to start a 5-year-long experiment that will provide some limited coverage of obesity ...

In today’s edition … Why young men turned to Trump ... Things are heating up in North Carolina … And you give us your ...

Proposed experiment would allow states and Medicare drug plans to cover GLP-1 drugs like Ozempic and Wegovy for obesity, The ...

The groups that pushed for Planned Parenthood to lose Medicaid reimbursement remain confident that a federal judge's ruling ...

The Trump administration is planning an experiment to cover weight loss drugs under Medicare and Medicaid, potentially ...

The Washington Post reported the CMS is considering a plan that could allow Medicare plans to pay for the drugs.